0 Commentarii
0 Distribuiri
1K Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Pharmaceutical Cold Chain Logistics Market Surges at 15.2% CAGR to 2031Market Overview The Global Pharmaceutical Cold Chain Logistics Market reached US$18.61 Billion in 2024 and is expected to reach US$27.11 Billion by 2033, growing with a CAGR of 4.3% during the forecast period 2025-2033. The Pharmaceutical Cold Chain Logistics Market is expanding due to the increasing demand for temperature-sensitive pharmaceuticals like vaccines and biologics. This market...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Cold Chain Market: Emerging Technologies and Global Growth TrendsThe Cold Chain Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Cold Chain Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and future potential to provide a...0 Commentarii 0 Distribuiri 26 Views 0 previzualizare
-
How Data Analytics Is Improving Pharmaceutical Cold Chain ManagementPolaris Market Research releases its new research report on the Biopharma Cold Chain Logistics market, which provides comprehensive insight into the current market landscape and future outlook. It discusses all the major forces that can help drive growth in the market. This report studies the effect of rising demand, technology, applications, investments, and competition. It offers a...0 Commentarii 0 Distribuiri 690 Views 0 previzualizare
-
Why Is the Healthcare Cold Chain Logistics Market Expanding Rapidly Worldwide?Healthcare Cold Chain Logistics Market Set to Reach USD 25.69 Billion by 2032 as Demand for Vaccines and Biologics Surges The global Healthcare Cold Chain Logistics Market is entering a strong growth phase, fueled by rising demand for temperature-sensitive pharmaceuticals, vaccines, and biologics. Valued at USD 15.88 billion in 2024, the market is projected to reach nearly USD 25.69...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare